 <p><strong>Give Kids a Chance Act</strong> <b>of 2022</b></p> <p>This bill authorizes the Food and Drug Administration (FDA) to take various actions regarding pediatric cancer treatments, such as requiring pediatric cancer trials involving a combination of drugs when an applicant seeks market approval for a new drug (or biological product). </p>